Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells.
Chen WC, To MD, Westcott PMK, Delrosario R, Kim IJ, Philips M, Tran Q, Bollam SR, Goodarzi H, Bayani N, Mirzoeva O, Balmain A.
Chen WC, et al. Among authors: balmain a.
Nat Commun. 2021 Jul 13;12(1):4288. doi: 10.1038/s41467-021-24498-7.
Nat Commun. 2021.
PMID: 34257283
Free PMC article.